NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/06/2026
Voltar para busca
Dado oficial do USPTO
NANOBODIES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
61
Atualização mais recente
11/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
10/06/2004
Data de registro
20/12/2005
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/06/2026
Última transação
11/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Gand, BE
Examinador
GUSTASON, ANNE C
Localização atual
Historical data usage
Titulares e representantes
Titulares
ABLYNX
ABLYNX N.V.
Representantes
Alexandra Kochian Fross Zelnick Lehrman & Zissu, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations and antibodies for the treatment of cardiovascular diseasesallergyimmune and inflammatory diseasesmetabolic diseasescancerdiseases of the central nervous systeminfectious diseases; veterinary preparations for treating livestock diseasesallergyimmune and inflammatory diseasesmetabolic diseasesdiseases of the central nervous systeminfectious diseases; diagnostic preparations for medical or veterinary purposes; therapeutic preparations and antibodies for medical and veterinary use for the treatment of cardiovascular diseasesallergyimmune and inflammatory diseasesmetabolic diseasescancerdiseases of the central nervous systeminfectious diseases ; diagnostic biological cultures for clinical medical and veterinary use; insecticides
Classe 42
Laboratory technicianchemistengineering and biotechnology services; scientific research and laboratory research in the fields of medicalbacteriological and biotechnical fields; biotechnical research technical consultation and research in the field of biotechnological research ; industrial property consultancy; research with respect to issues of industrial property protection in relation to the biotechnical field
Publicações
Histórico de despachos e eventos da marca no USPTO.
61 publicações encontradas
71AG
REGISTERED-SEC.71 ACCEPTED
05/06/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/06/2026
ES71
TEAS SECTION 71 RECEIVED
18/02/2026
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
20/12/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
17/05/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/04/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/10/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/10/2019
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
19/05/2017
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
21/11/2016
XXCR
GENERIC MADRID TRANSACTION CREATED
21/11/2016
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
17/11/2016
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
19/09/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
31/01/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
19/01/2016
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
19/01/2016
71AG
REGISTERED-SEC.71 ACCEPTED
19/01/2016
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
19/01/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15/01/2016
71AF
REGISTERED-SEC.71 FILED
07/12/2015
15AF
REGISTERED - SEC. 15 AFFIDAVIT FILED
07/12/2015
ES71
TEAS SECTION 71 RECEIVED
07/12/2015
E15R
TEAS SECTION 15 RECEIVED
07/12/2015
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
26/06/2015
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
28/02/2015
XXCR
GENERIC MADRID TRANSACTION CREATED
28/02/2015
IRIV
IRREGULARITY ON INVALIDATION RECEIVED FROM IB
17/02/2015
RNWL
INTERNATIONAL REGISTRATION RENEWED
26/06/2014
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/06/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
28/02/2014
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
05/10/2013
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED
05/02/2013
71AG
REGISTERED-SEC.71 ACCEPTED
05/02/2013
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
24/01/2013
PR71
POST REGISTRATION ACTION MAILED - SEC.71
07/08/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/08/2012
ES71
TEAS SECTION 71 RECEIVED
19/06/2012
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/12/2010
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/09/2007
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/04/2007
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/04/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/04/2007
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/08/2006
FIMP
FINAL DISPOSITION PROCESSED
14/08/2006
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/08/2006
R.PR
REGISTERED-PRINCIPAL REGISTER
20/12/2005
PUBO
PUBLISHED FOR OPPOSITION
27/09/2005
NPUB
NOTICE OF PUBLICATION
07/09/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
16/08/2005
ALIE
ASSIGNED TO LIE
12/08/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/08/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
22/07/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/07/2005
PAPER RECEIVED
15/07/2005
RFNT
REFUSAL PROCESSED BY IB
03/03/2005
CNRT
NON-FINAL ACTION MAILED
24/01/2005
CNRT
NON-FINAL ACTION WRITTEN
13/01/2005
DOCK
ASSIGNED TO EXAMINER
10/01/2005
NWAP
NEW APPLICATION ENTERED
08/10/2004
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/10/2004
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NANOBODIES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.